J. Woods

发表

Characterization of the complex morphinan derivative BU72 as a high efficacy, long-lasting mu-opioid receptor agonist.

S. Breeden, M. Aceto, C. Neilan, 2004, European journal of pharmacology.

Effects of selective dopaminergic compounds on a delay-discounting task

Mikhail N. Koffarnus, A. Newman, K. Rice, 2011, Behavioural pharmacology.

The economics of drug abuse: a quantitative assessment of drug demand.

S. Hursh, J. Woods, C. Galuska, 2005, Molecular interventions.

Dopamine Agonist-Induced Yawning in Rats: A Dopamine D3 Receptor-Mediated Behavior

A. Newman, J. Witkin, J. Woods, 2005, Journal of Pharmacology and Experimental Therapeutics.

Yawning and locomotor behavior induced by dopamine receptor agonists in mice and rats

D. Grandy, A. Newman, J. Woods, 2010, Behavioural pharmacology.

Introduction to receptor theory

J. Woods, 1991, Pharmacology Biochemistry and Behavior.

Stimulation of guanosine-5'-o-(3-[35S]thio)triphosphate binding in digitonin-permeabilized C6 rat glioma cells: evidence for an organized association of mu-opioid receptors and G protein.

J. Woods, J. Traynor, I. McFadyen, 2001, The Journal of pharmacology and experimental therapeutics.

Effect of ethanol and of noise on reaction time in the monkey: Variation with stimulus level

D. Moody, W. Stebbins, J. Woods, 1980, Psychopharmacology.

Interaction of morphine and naltrexone on oral ethanol self‐administration in rhesus monkeys

E. C. Kane, J. Woods, K. Williams, 2001, Behavioural pharmacology.

Quadazocine decreases responding reinforced by ethanol, sucrose, and phencyclidine fluid deliveries in rhesus monkeys: comparison to naltrexone’s effects

J. Woods, K. Williams, E. Pakarinen, 1999, Psychopharmacology.

Naltrexone reduces ethanol- and/or water-reinforced responding in rhesus monkeys: effect depends upon ethanol concentration.

J. Woods, K. Williams, 1999, Alcoholism, clinical and experimental research.

Zipeprol: preclinical assessment of abuse potential.

J. Woods, E. Butelman, E. Bowman, 1996, Drug and alcohol dependence.

Electrospray sample deposition for matrix-assisted laser desorption/ionization (MALDI) and atmospheric pressure MALDI mass spectrometry with attomole detection limits.

R. Kennedy, K. Nolkrantz, J. Woods, 2004, Rapid communications in mass spectrometry : RCM.

Abuse liability of flunitrazepam.

J. Woods, G. Winger, G. Winger, 1997, Journal of clinical psychopharmacology.

Behavioral pharmacology of buprenorphine: issues relevant to its potential in treating drug abuse.

J. Woods, G. Winger, C. France, 1992, NIDA research monograph.

Reinforcing effects, discriminative stimulus effects, and physical dependence liability of buprenorphine.

J. Woods, S. Negus, 1995 .

kappa-Opioid receptor binding populations in rhesus monkey brain: relationship to an assay of thermal antinociception.

H. Mosberg, J. Woods, E. Butelman, 1998, The Journal of pharmacology and experimental therapeutics.

GR89,696: a potent kappa-opioid agonist with subtype selectivity in rhesus monkeys.

J. Vivian, M. Ko, J. Woods, 2001, The Journal of pharmacology and experimental therapeutics.

GR89,696: A Potent κ-Opioid Agonist with Subtype Selectivity in Rhesus Monkeys

J. Vivian, M. Ko, J. Woods, 2001 .

Studies of micro-, kappa-, and delta-opioid receptor density and G protein activation in the cortex and thalamus of monkeys.

M. Ko, J. Woods, J. Traynor, 2003, The Journal of pharmacology and experimental therapeutics.

Evaluation of new compounds for opioid activity: 1982 annual report.

J. Woods, G. Winger, J. Katz, 1983, NIDA research monograph.

The discriminative stimulus effects of clozapine in pigeons: involvement of 5-hydroxytryptamine1C and 5-hydroxytryptamine2 receptors.

J. Woods, S. A. Vanecek, E. M. Hoenicke, 1992, The Journal of pharmacology and experimental therapeutics.

Codeine- and cocaine-reinforced responding in rhesus monkeys: effects of dose on response rates under a fixed-ratio schedule.

J. Woods, D. A. Downs, 1974, The Journal of pharmacology and experimental therapeutics.

Comparison of the muscarinic antagonist effects of scopolamine and L-687,306

E. Jutkiewicz, J. Woods, G. Winger, 2020, Behavioural pharmacology.

Serotonin synthesis inhibition reveals distinct mechanisms of action for MDMA and its enantiomers in the mouse

J. Woods, R. D. L. Garza, W. Fantegrossi, 2005, Psychopharmacology.

Glucocorticoid-reinforced responding in the rhesus monkey

J. Woods, J. Broadbear, G. Winger, 1999, Psychopharmacology.

Concurrent schedules of cocaine injection in rhesus monkeys: dose variations under independent and non-independent variable-interval procedures.

J. Woods, C. Iglauer, M. Llewellyn, 1975, Pharmacological reviews.

Patterns of nicotinic receptor antagonism II: cardiovascular effects in rats.

E. Jutkiewicz, K. Rice, F. Carroll, 2013, Drug and alcohol dependence.

Behavioral variables affecting the development of amphetamine tolerance

J. Woods, C. Schuster, W. Dockens, 2004, Psychopharmacologia.

The competitive N-methyl-D-aspartate (NMDA) antagonist CGS 19755 attenuates the rate-decreasing effects of NMDA in rhesus monkeys without producing ketamine-like discriminative stimulus effects.

P. Ornstein, J. Woods, C. France, 1989, European journal of pharmacology.

Nonpeptidic delta-opioid receptor agonists reduce immobility in the forced swim assay in rats.

E. Jutkiewicz, K. Rice, J. Woods, 2002, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

BU74, a complex oripavine derivative with potent kappa opioid receptor agonism and delayed opioid antagonism.

S. Breeden, M. Aceto, C. Neilan, 2005, European journal of pharmacology.

Self-administration of fentanyl, cocaine and ketamine: effects on the pituitary–adrenal axis in rhesus monkeys

J. Woods, J. Broadbear, G. Winger, 2004, Psychopharmacology.

Naltrexone decreases D-amphetamine and ethanol self-administration in rhesus monkeys

D. Deaver, J. Woods, R. Dean, 2011, Behavioural pharmacology.

Dynorphin A (1-8) analog, E-2078, crosses the blood-brain barrier in rhesus monkeys.

B. Chait, J. Woods, E. Butelman, 1997, The Journal of pharmacology and experimental therapeutics.

Kappa-opioid receptor-mediated effects of the plant-derived hallucinogen, salvinorin A, on inverted screen performance in the mouse

J. Woods, W. Fantegrossi, L. J. Valdes, 2005, Behavioural pharmacology.

Ring-constrained orvinols as analogs of buprenorphine: differences in opioid activity related to configuration of C(20) hydroxyl group.

A. Coop, J. Woods, J. Lewis, 1999, The Journal of pharmacology and experimental therapeutics.

Direct determination of ecgonine methyl ester and cocaine in rat plasma, utilizing on-line sample extraction coupled with rapid chromatography/quadrupole orthogonal acceleration time-of-flight detection.

T. Baird, J. Woods, P. Jeanville, 2000, Journal of pharmaceutical and biomedical analysis.

Comparison of fixed-ratio and progressive-ratio schedules of maintenance of stimulant drug-reinforced responding.

J. Woods, G. Winger, 1985, Drug and alcohol dependence.

Use af ir : tyIivo apparent pA 2 analysis in assessment of opioid abuse liability

J. Woods, C. I. Frmce, 2002 .

Kappa receptor mediated opioid dependence in rhesus monkeys.

J. Woods, D. Gmerek, 1986, Life sciences.

Substitution and primary dependence studies in animals.

J. Woods, D. Gmerek, James H Woods, 1985, Drug and alcohol dependence.

Discriminative stimulus effects of narcotics: evidence for multiple receptor-mediated actions.

J. Woods, S. Herling, 1981, Life sciences.

Narcotic-reinforced responding: a rapid evaluation procedure.

J. Woods, 1980, Drug and alcohol dependence.

Interaction of 5-HT2A and 5-HT2C Receptors in R(−)-2,5-Dimethoxy-4-iodoamphetamine-Elicited Head Twitch Behavior in Mice

K. Rice, J. Woods, M. Cohen, 2010, Journal of Pharmacology and Experimental Therapeutics.

Abuse liability and the regulatory control of therapeutic drugs: untested assumptions.

J. Woods, 1990, Drug and alcohol dependence.

Binding affinity and selectivity of opioids at mu, delta and kappa receptors in monkey brain membranes.

P. Emmerson, J. Woods, F. Medzihradsky, 1994, The Journal of pharmacology and experimental therapeutics.

A Thermally Stable Form of Bacterial Cocaine Esterase: A Potential Therapeutic Agent for Treatment of Cocaine Abuse

R. Sunahara, C. Zhan, J. Woods, 2010, Molecular Pharmacology.

Opioid efficacy in a C6 glioma cell line stably expressing the human kappa opioid receptor.

H. Akil, J. Woods, A. Mansour, 1999, The Journal of pharmacology and experimental therapeutics.

Prevention and reversal by cocaine esterase of cocaine-induced cardiovascular effects in rats.

R. Sunahara, Z. Cooper, J. Woods, 2010, Drug and alcohol dependence.

Patterns of Nicotinic Receptor Antagonism: Nicotine Discrimination Studies

E. Jutkiewicz, K. Rice, J. Woods, 2011, Journal of Pharmacology and Experimental Therapeutics.

Facilitation of Cardiac Vagal Activity by CRF-R1 Antagonists during Swim Stress in Rats

K. Rice, J. Woods, S. Wood, 2006, Neuropsychopharmacology.

Intranasal Opioid Administration in Rhesus Monkeys: PET Imaging and Antinociception

X. Shao, R. Koeppe, P. Saccone, 2016, The Journal of Pharmacology and Experimental Therapeutics.

Enzyme-Based Cocaine Pharmacotherapies: Current Status and Projections for the Future

C. Zhan, J. Woods, 2016 .

Natural and artificial enzymes against cocaine. I. Monoclonal antibody 15A10 and the reinforcing effects of cocaine in rats.

T. Baird, D. Landry, J. Woods, 2000, The Journal of pharmacology and experimental therapeutics.

Cocaine Esterase Prevents Cocaine-Induced Toxicity and the Ongoing Intravenous Self-Administration of Cocaine in Rats

R. Sunahara, C. Zhan, J. Woods, 2009, Journal of Pharmacology and Experimental Therapeutics.

LARGE SCALE PURIFICATION OF BUTYRYLCHOLINESTERASE FROM HUMAN PLASMA SUITABLE FOR INJECTION INTO MONKEYS; A POTENTIAL NEW THERAPEUTIC FOR PROTECTION AGAINST COCAINE AND NERVE AGENT TOXICITY.

O. Lockridge, L. Schopfer, J. Woods, 2005, The journal of medical, chemical, biological, and radiological defense.

Classification and nomenclature of phencyclidine and sigma receptor sites

Kenneth M. Johnson, P. Contreras, R. Quirion, 1987, Trends in Neurosciences.

Effects of mu, kappa, and delta opioid receptor agonists on the function of hypothalamic–pituitary–adrenal axis in monkeys

K. Rice, J. Woods, P. Mukhopadhyay, 2008, Psychoneuroendocrinology.

N-methyl-D-aspartate antagonism and phencyclidine-like activity: a drug discrimination analysis.

F. Colpaert, W. Koek, J. Woods, 1990, The Journal of pharmacology and experimental therapeutics.

A comparison of the physiological, behavioral, neurochemical and microglial effects of methamphetamine and 3,4-methylenedioxymethamphetamine in the mouse

K. T. Wakabayashi, J. Woods, R. D. L. Garza, 2008, Neuroscience.

Dynorphin A (1-8) analog, E-2078, is stable in human and rhesus monkey blood.

B. Chait, J. Woods, E. Butelman, 1997, The Journal of pharmacology and experimental therapeutics.

Effects of Intrathecally Administered Nociceptin/Orphanin FQ in Monkeys: Behavioral and Mass Spectrometric Studies

R. Kennedy, M. Ko, J. Woods, 2006, Journal of Pharmacology and Experimental Therapeutics.

Differential Responsivity of the Hypothalamic‐Pituitary‐Adrenal Axis to Glucocorticoid Negative‐Feedback and Corticotropin Releasing Hormone in Rats Undergoing Morphine Withdrawal: Possible Mechanisms Involved in Facilitated and Attenuated Stress Responses

H. Houshyar, M. Galigniana, W. Pratt, 2001, Journal of neuroendocrinology.

Paradoxical Effects of Chronic Morphine Treatment on the Temperature and Pituitary‐Adrenal Responses to Acute Restraint Stress: A Chronic Stress Paradigm

H. Houshyar, Z. Cooper, J. Woods, 2001, Journal of neuroendocrinology.

Attention-Deficit and Disruptive Behavior Disorders

C. McDougle, D. Posey, C. Buhusi, 2014 .

Discriminative stimulus effects of naltrexone in morphine-treated rhesus monkeys.

J. Woods, C. France, 1989, The Journal of pharmacology and experimental therapeutics.

Attention Deficit Hyperactivity Disorders: Animal Models

C. McDougle, D. Posey, C. Buhusi, 2014 .

Effects of self-administered cocaine on plasma adrenocorticotropic hormone and cortisol in male rhesus monkeys.

J. Woods, J. Broadbear, T. Cicero, 1999, The Journal of pharmacology and experimental therapeutics.

Cocaine-reinforced responding in rhesus monkeys: pharmacological attenuation of the hypothalamic-pituitary-adrenal axis response.

J. Woods, J. Broadbear, G. Winger, 1999, The Journal of pharmacology and experimental therapeutics.

Current benzodiazepine issues

J. Woods, G. Winger, 1995, Psychopharmacology.

Morphine, pentazocine and naloxone effects on responding under a multiple schedule of reinforcement in rhesus monkeys and pigeons.

J. Woods, D. A. Downs, 1976, The Journal of pharmacology and experimental therapeutics.

Competitive and uncompetitiveN-methyl-d-aspartate antagonist discriminations in pigeons: CGS 19755 and phencyclidine

J. Woods, S. Baron, 1995, Psychopharmacology.

Synthesis and In Vivo Brain Distribution of Carbon-11 Labeled δ Opioid Receptor Agonists 1

D. Jewett, J. Woods, J. Traynor, 2011 .

Characterization of opioid agonist efficacy in a C6 glioma cell line expressing the mu opioid receptor.

H. Akil, P. Emmerson, J. Woods, 1996, The Journal of pharmacology and experimental therapeutics.

The delta receptor

J. Woods, F. Porreca, Kwen-Jen Chang, 2003 .

On the nature of directed behavior to drug-associated light cues in rhesus monkeys (Macaca mulatta).

J. Woods, M. Reilly, Sonja I Berndt, 2016, Behavior analysis.

Analgesic, respiratory and heart rate effects of cannabinoid and opioid agonists in rhesus monkeys: antagonist effects of SR 141716A.

J. Vivian, J. Woods, E. Butelman, 1998, The Journal of pharmacology and experimental therapeutics.

Separation of the convulsions and antidepressant-like effects produced by the delta-opioid agonist SNC80 in rats

E. Jutkiewicz, K. Rice, J. Woods, 2005, Psychopharmacology.

Fumaroylamino-4,5-epoxymorphinans and Related Opioids with Irreversible μ Opioid Receptor Antagonist Effects

Mark P Thomas, M. Aceto, L. Harris, 2012, Journal of medicinal chemistry.

Comparison of Receptor Mechanisms and Efficacy Requirements for δ-Agonist-Induced Convulsive Activity and Antinociception in Mice

J. Pintar, K. Rice, J. Woods, 2002, Journal of Pharmacology and Experimental Therapeutics.

Effects of Butorphanol on Morphine-induced Itch and Analgesia in Primates

J. Woods, Heeseung Lee, M. Ko, 2007, Anesthesiology.

Effects of a long-acting mutant bacterial cocaine esterase on acute cocaine toxicity in rats.

R. Sunahara, J. Woods, G. Collins, 2011, Drug and alcohol dependence.

Amelioration of the Cardiovascular Effects of Cocaine in Rhesus Monkeys by a Long-Acting Mutant Form of Cocaine Esterase

R. Sunahara, J. Woods, N. Lukacs, 2011, Neuropsychopharmacology.

Behavioral Effects of a Synthetic Agonist Selective for Nociceptin/Orphanin FQ Peptide Receptors in Monkeys

J. Woods, E. Prinssen, C. Galuska, 2009, Neuropsychopharmacology.

Pro-erectile Effects of Dopamine D 2 -like Agonists are Mediated by the D 3 Receptor in Rats and Mice

D. Grandy, Jianyong Chen, A. Newman, 2008 .

Differential in Vivo Potencies of Naltrexone and 6β-Naltrexol in the Monkey

M. Ko, J. Woods, J. Traynor, 2006, Journal of Pharmacology and Experimental Therapeutics.

Synthesis and biological evaluation of 14-alkoxymorphinans. 18. N-substituted 14-phenylpropyloxymorphinan-6-ones with unanticipated agonist properties: extending the scope of common structure-activity relationships.

M. Aceto, L. Harris, A. Coop, 2003, Journal of medicinal chemistry.

14-Phenylpropyloxymorphinan-6-ones with Unanticipated Agonist Properties: Extending the Scope of Common Structure-Activity Relationships

Received December, M. Aceto, L. Harris, 2003 .

BU48: A Novel Buprenorphine Analog That Exhibits δ-Opioid-Mediated Convulsions but Not δ-Opioid-Mediated Antinociception in Mice

A. Coop, S. Husbands, J. Lewis, 2000 .

Methocinnamox is a potent, long-lasting, and selective antagonist of morphine-mediated antinociception in the mouse: comparison with clocinnamox, beta-funaltrexamine, and beta-chlornaltrexamine.

T. Sumpter, S. Husbands, J. Woods, 2000, Journal of Pharmacology and Experimental Therapeutics.

Stimulation of guanosine-5'-O-(3-[35S]thio)triphosphate binding by endogenous opioids acting at a cloned mu receptor.

H. Akil, J. Woods, J. Traynor, 1998, The Journal of pharmacology and experimental therapeutics.

Opioid efficacy in a C6 glioma cell line stably expressing the delta opioid receptor.

H. Akil, P. Emmerson, J. Woods, 1997, The Journal of pharmacology and experimental therapeutics.

Opioid Efficacy in a C 6 Glioma Cell Line Stably Expressing the Delta Opioid Receptor 1

H. Akil, P. Emmerson, J. Woods, 1997 .

Systemic effects of E-2078, a stabilized dynorphin A(1–8) analog, in rhesus monkeys

J. Vivian, J. Woods, E. Butelman, 1999, Psychopharmacology.

In vitro biotransformation of dynorphin A (1-17) is similar in human and rhesus monkey blood as studied by matrix-assisted laser desorption/ionization mass spectrometry.

B. Chait, J. Woods, E. Butelman, 1996, The Journal of pharmacology and experimental therapeutics.

The effects of CRF antagonists, antalarmin, CP154,526, LWH234, and R121919, in the forced swim test and on swim-induced increases in adrenocorticotropin in rats

H. Houshyar, E. Jutkiewicz, K. Rice, 2005, Psychopharmacology.

Comparison of opioid agonists in maintaining responding and in suppressing morphine withdrawal in rhesus monkeys

J. Woods, A. Young, H. Swain, 1981, Psychopharmacology.

Discriminative stimulus effects of etorphine in rhesus monkeys

J. Woods, S. Herling, 1981, Psychopharmacology.

Some thoughts on the relations between animal and human drug-taking

J. Woods, 1983, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Independent central and peripheral mediation of morphine-induced inhibition of gastrointestinal transit in rats.

J. Woods, A. Cowan, D. Gmerek, 1986, The Journal of pharmacology and experimental therapeutics.

Stereospecific binding of 3H-phencyclidine in brain membranes.

J. Woods, F. Medzihradsky, R. Hampton, 1982, Life sciences.

Differential effects of systemically administered nor-binaltorphimine (nor-BNI) on κ-opioid agonists in the mouse writhing assay

J. Woods, E. Butelman, J. Broadbear, 1994, Psychopharmacology.

Drug and Reinforcement History as Determinants of the Response-Maintaining Effects of Quinpirole in the Rat

J. Woods, G. Collins, 2007, Journal of Pharmacology and Experimental Therapeutics.

Nantenine: an antagonist of the behavioral and physiological effects of MDMA in mice

T. Ullrich, Y. Ohizumi, K. Rice, 2004, Psychopharmacology.

Pharmacological characterization of the effects of 3,4-methylenedioxymethamphetamine ("ecstasy") and its enantiomers on lethality, core temperature, and locomotor activity in singly housed and crowded mice

T. Ullrich, K. Rice, J. Woods, 2003, Psychopharmacology.

The reinforcing property of ethanol in the rhesus monkey

J. Woods, A. J. Karoly, G. Winger, 1978, Psychopharmacology.

Opioid Agonist Effects on Mouse Writhing After Irreversible Mu Receptor Blockade With Clocinnamox

J. Lewis, J. Woods, J. Broadbear, 1995 .

Receptor binding, antagonist, and withdrawal precipitating properties of opiate antagonists.

J. Woods, R. Valentino, J. Katz, 1983, Life sciences.

Comparison of naltrexone and quaternary naltrexone after systemic and intracerebroventricular administration in pigeons

Jill U. Adams, J. Woods, C. France, 1987, Neuropharmacology.

Intracerebroventricular drug administration in pigeons

Jill U. Adams, J. Woods, C. France, 1985, Pharmacology Biochemistry and Behavior.

Quaternary naltrexone: evidence for the central mediation of discriminative stimulus effects of narcotic agonists and antagonists.

J. Woods, R. Valentino, F. Medzihradsky, 1981, The Journal of pharmacology and experimental therapeutics.

Receptor mechanisms of opioid drug discrimination.

W. Essman, J. Woods, A. Young, 1988, Psychopharmacology series.

Pharmacokinetic evidence for the long-lasting effect of nor-binaltorphimine, a potent kappa opioid receptor antagonist, in mice

J. Woods, M. Ko, N. Kiguchi, 2013, Neuroscience Letters.

Kappa opioid antagonist effects of systemically administered nor-binaltorphimine in a thermal antinociception assay in rhesus monkeys.

J. Woods, S. Negus, E. Butelman, 1993, The Journal of pharmacology and experimental therapeutics.

Reversal and Prevention of the Respiratory-Depressant Effects of Heroin by the Novel μ-Opioid Receptor Antagonist Methocinnamox in Rhesus Monkeys

S. Husbands, J. Woods, C. France, 2018, The Journal of Pharmacology and Experimental Therapeutics.

Butorphanol: characterization of agonist and antagonist effects in rhesus monkeys.

J. Woods, E. Butelman, G. Zernig, 1995, The Journal of pharmacology and experimental therapeutics.

Opioid thermal antinociception in rhesus monkeys: receptor mechanisms and temperature dependency.

J. Woods, E. Butelman, B. Decosta, 1993, The Journal of pharmacology and experimental therapeutics.

Corticotropin-Releasing Hormone Antagonists, Astressin B and Antalarmin: Differing Profiles of Activity in Rhesus Monkeys

K. Rice, J. Rivier, J. Woods, 2004, Neuropsychopharmacology.

The steroid 17alpha-acetoxy-6-dimethylaminomethyl-21-fluoro-3-ethoxy-pregna-3, 5-dien-20-one (SC17599) is a selective mu-opioid agonist: implications for the mu-opioid pharmacophore.

H. Houshyar, L. Liu-Chen, J. Woods, 2000, Molecular pharmacology.

Limitations on the antagonistic actions of opioid antagonists.

J. Woods, A. Young, 1982, Federation proceedings.

Pharmacological analysis of the discriminative stimulus characteristics of ethylketazocine in the rhesus monkey.

J. Woods, A. Young, D. Hein, 1981, The Journal of pharmacology and experimental therapeutics.

Behavioral and neurobiological effects of the enkephalinase inhibitor RB101 relative to its antidepressant effects.

S. Watson, E. Jutkiewicz, K. Rice, 2006, European journal of pharmacology.

Peptidic delta opioid receptor agonists produce antidepressant-like effects in the forced swim test and regulate BDNF mRNA expression in rats

S. Watson, G. Balboni, E. Jutkiewicz, 2006, Brain Research.

Chronic administration of the delta opioid receptor agonist (+)BW373U86 and antidepressants on behavior in the forced swim test and BDNF mRNA expression in rats

S. Watson, K. Rice, J. Woods, 2005, Psychopharmacology.

Identification and Characterization of ML321: a Novel and Highly Selective D2 Dopamine Receptor Antagonist with Efficacy in Animal Models that Predict Atypical Antipsychotic Activity

R. Rodriguiz, W. Wetsel, R. Mach, 2022, bioRxiv.

Drugs as Reinforcers.

J. Woods, 1989 .

Acquisition of responding with a remifentanil-associated conditioned reinforcer in the rat

J. Woods, Jeremiah W. Bertz, 2013, Psychopharmacology.

Convulsant activity of a non-peptidic δ-opioid receptor agonist is not required for its antidepressant-like effects in Sprague-Dawley rats

E. Jutkiewicz, K. Rice, J. Woods, 2002, Psychopharmacology.

Tolerance to the cataleptic effect of the N-methyl-D-aspartate (NMDA) receptor antagonists in pigeons: cross-tolerance between PCP-like compounds and competitive NMDA antagonists.

J. Woods, Y. Lu, C. France, 1992, The Journal of pharmacology and experimental therapeutics.

Constitutive activity of the delta-opioid receptor expressed in C6 glioma cells: identification of non-peptide delta-inverse agonists.

H. Akil, C. Neilan, J. Woods, 1999, British journal of pharmacology.

3,4-Methylenedioxymethamphetamine (MDMA, "ecstasy") and its stereoisomers as reinforcers in rhesus monkeys: serotonergic involvement

T. Ullrich, K. Rice, J. Woods, 2002, Psychopharmacology.

Ultra-long antagonism of kappa opioid agonist-induced diuresis by intracisternal nor-binaltorphimine in monkeys

M. Ko, J. Woods, M. Ko, 2003, Brain Research.

Nor‐binaltorphimine: an ultra‐long acting kappa‐opioid antagonist in pigeons

J. Woods, D. C. Jewott, 1995, Behavioural pharmacology.

Constitutive activity of the δ‐opioid receptor expressed in C6 glioma cells: identification of non‐peptide δ‐inverse agonists

H. Akil, C. Neilan, J. Woods, 1999 .

Characterization of scratching responses in rats following centrally administered morphine or bombesin

M. Ko, J. Woods, Heeseung Lee, 2003, Behavioural pharmacology.

Activation of κ-Opioid Receptors Inhibits Pruritus Evoked by Subcutaneous or Intrathecal Administration of Morphine in Monkeys

H. Mosberg, M. Ko, J. Woods, 2003, Journal of Pharmacology and Experimental Therapeutics.

Buprenorphine antagonism of mu opioids in the rhesus monkey tail-withdrawal procedure.

J. Woods, G. Zernig, E. Walker, 1995, The Journal of pharmacology and experimental therapeutics.

The Spinal Antinociceptive Effects of Endomorphins in Rats: Behavioral and G Protein Functional Studies

J. Woods, J. Traynor, M. Ko, 2008, Anesthesia and analgesia.

The effects of the phyllolitorin analogue [desTrp3,Leu8]phyllolitorin on scratching induced by bombesin and related peptides in rats

Mark D. Johnson, H. Mosberg, J. Woods, 1999, Brain Research.

The role of peripheral mu opioid receptors in the modulation of capsaicin-induced thermal nociception in rhesus monkeys.

J. Woods, E. Butelman, M. Ko, 1998, The Journal of pharmacology and experimental therapeutics.

Differentiation of kappa opioid agonist-induced antinociception by naltrexone apparent pA2 analysis in rhesus monkeys.

J. Woods, J. Traynor, E. Butelman, 1998, The Journal of pharmacology and experimental therapeutics.

In vivo determination of mu opioid receptor turnover in rhesus monkeys after irreversible blockade with clocinnamox.

J. Woods, E. Butelman, G. Zernig, 1994, The Journal of pharmacology and experimental therapeutics.

Effects of opioid agonists selective for mu, kappa and delta opioid receptors on schedule-controlled responding in rhesus monkeys: antagonism by quadazocine.

J. Woods, S. Negus, T. F. Burke, 1993, Journal of Pharmacology and Experimental Therapeutics.

Prostaglandin E2-induced thermal hyperalgesia and its reversal by morphine in the warm-water tail-withdrawal procedure in rhesus monkeys.

J. Woods, S. Negus, E. Butelman, 1993, The Journal of pharmacology and experimental therapeutics.

A tail withdrawal procedure for assessing analgesic activity in rhesus monkeys.

L. Dykstra, J. Woods, J H Woods, 1986, Journal of pharmacological methods.

Acute dependence on, but not tolerance to, heroin and morphine as measured by respiratory effects in rhesus monkeys.

J. Woods, C. Paronis, S. Kishioka, 2000, European journal of pharmacology.

Intracisternal nor-binaltorphimine distinguishes central and peripheral kappa-opioid antinociception in rhesus monkeys.

H. Mosberg, J. Woods, E. Butelman, 1999, The Journal of pharmacology and experimental therapeutics.

Comparison of kappa opioids in rhesus monkeys: behavioral effects and receptor binding affinities.

J. Woods, C. France, F. Medzihradsky, 1994, The Journal of pharmacology and experimental therapeutics.

Kappa opioids in rhesus monkeys. III. Dependence associated with chronic administration.

L. Dykstra, J. Woods, D. Gmerek, 1987, The Journal of pharmacology and experimental therapeutics.

Characterization of the Discriminative Stimulus Effects of a NOP Receptor Agonist Ro 64-6198 in Rhesus Monkeys

P. Saccone, K. Rice, J. Woods, 2016, The Journal of Pharmacology and Experimental Therapeutics.

The effects of nociceptin/orphanin FQ receptor agonist Ro 64-6198 and diazepam on antinociception and remifentanil self-administration in rhesus monkeys

Christopher A. Podlesnik, J. Woods, E. Prinssen, 2010, Psychopharmacology.

Orphanin FQ inhibits capsaicin‐induced thermal nociception in monkeys by activation of peripheral ORL1 receptors

K. Rice, M. Ko, J. Woods, 2002, British journal of pharmacology.

Methoclocinnamox: agonist and antagonist effects of a novel long-lasting opioid in rhesus monkeys.

J. Woods, E. Butelman, J. Lewis, 1996, Journal of Pharmacology and Experimental Therapeutics.

Clocinnamox antagonism of opioid suppression of schedule-controlled responding in rhesus monkeys

J. Woods, S. Negus, E. Butelman, 1996, Psychopharmacology.

Potential Irreversible Ligands for Opioid Receptors. Cinnamoyl Derivatives of β‐Naltrexamine

J. Lewis, J. Woods, J. Broadbear, 1996, The Journal of pharmacy and pharmacology.

Genetic variance in nociception and its relationship to the potency of morphine-induced analgesia in thermal and chemical tests

G. Elmer, J. Pieper, J. Woods, 1998, Pain.

N-Substituted 14-Phenylpropyloxymorphinan-6-ones with Unanticipated Agonist Properties : Extending the Scope of Common Structure-Activity Relationships

M. Aceto, L. Harris, A. Coop, 2022 .

The Convulsive and Electroencephalographic Changes Produced by Nonpeptidic δ-Opioid Agonists in Rats: Comparison with Pentylenetetrazol

E. Jutkiewicz, K. Rice, J. Woods, 2006, Journal of Pharmacology and Experimental Therapeutics.

Abuse liability of benzodiazepines.

J L Katz, J. Woods, G. Winger, 1987, Pharmacological reviews.

Hallucinogen-like actions of 5-methoxy-N,N-diisopropyltryptamine in mice and rats

J. C. Winter, R. Rabin, A. Coop, 2006, Pharmacology Biochemistry and Behavior.

Alcoholism and animals.

J. Woods, G. Winger, 1974, Preventive medicine.

Alcoholism and Animals1

J. Woods, G. Winger, 1974 .

Effects of clonidine, dexmedetomidine and xylazine on thermal antinociception in rhesus monkeys.

J. Woods, E. Butelman, 1993, The Journal of pharmacology and experimental therapeutics.

Differential binding properties of oripavines at cloned μ- and δ-opioid receptors

H. Akil, J. Woods, J. Traynor, 1999 .

Clocinnamox dose-dependently antagonizes morphine-analgesia and [3H]DAMGO binding in rats.

J. Woods, C. Paronis, 1997, European journal of pharmacology.

Nalorphine-induced changes in morphine self-administration in rhesus monkeys.

S. Goldberg, J. Woods, C. Schuster, 1971, The Journal of pharmacology and experimental therapeutics.

Mechanism of clocinnamox blockade of opioid receptors: evidence from in vitro and ex vivo binding and behavioral assays.

J. Woods, G. Zernig, J. Lewis, 1996, The Journal of pharmacology and experimental therapeutics.

Ethanol effects in pigeons trained to discriminate MK‐801, PCP or CGS‐197551

J. Woods, E. R. Butelman, S. P. Baron, 1993, Behavioural pharmacology.

Synthesis and in vivo brain distribution of carbon-11-labeled δ-opioid receptor agonists.

Michael R Kilbourn, D. Jewett, S. Husbands, 2010, Nuclear medicine and biology.

The δ-Opioid Receptor Agonist SNC80 [(+)-4-[α(R)-α-[(2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl]-(3-methoxybenzyl)-N,N-diethylbenzamide] Synergistically Enhances the Locomotor-Activating Effects of Some Psychomotor Stimulants, but Not Direct Dopamine Agonists, in Rats

E. Jutkiewicz, K. Rice, J. Woods, 2008, Journal of Pharmacology and Experimental Therapeutics.

The (cid:1) -Opioid Receptor Agonist SNC80 [( (cid:1) )-4-[ -[(2 ,5 N , N -diethylbenzamide] Synergistically Enhances the Locomotor-Activating Effects of Some Psychomotor Stimulants, but Not Direct Dopamine Agonists, in Rats

E. Jutkiewicz, K. Rice, J. Woods, 2008 .

Comparison of Peptidic and Nonpeptidic δ-Opioid Agonists on Guanosine 5′-O-(3-[35S]thio)triphosphate ([35S]GTPγS) Binding in Brain Slices from Sprague-Dawley Rats

E. Jutkiewicz, K. Rice, J. Woods, 2005, Journal of Pharmacology and Experimental Therapeutics.

δ-Opioid Agonists: Differential Efficacy and Potency of SNC80, Its 3-OH (SNC86) and 3-Desoxy (SNC162) Derivatives in Sprague-Dawley Rats

E. Jutkiewicz, K. Rice, J. Woods, 2004, Journal of Pharmacology and Experimental Therapeutics.

Comparison of peptidic and nonpeptidic delta-opioid agonists on [ 35 S ] GTP γ S binding in brain slices from Sprague-Dawley rats

E. Jutkiewicz, K. Rice, J. Woods, 2004 .

Nonpeptidic δ-opioid Receptor Agonists Reduce Immobility in the Forced Swim Assay in Rats

E. Jutkiewicz, K. Rice, J. Woods, 2002, Neuropsychopharmacology.

Effects of sex and remifentanil dose on rats’ acquisition of responding for a remifentanil-conditioned reinforcer

J. Woods, Jeremiah W. Bertz, Emily L. Jackson, 2016, Behavioural pharmacology.

Effects of pramipexole on the acquisition of responding with opioid-conditioned reinforcement in the rat

Jianyong Chen, J. Woods, Jeremiah W. Bertz, 2014, Psychopharmacology.

Convulsive effects of systemic administration of the delta opioid agonist BW373U86 in mice.

H. Mosberg, J. Woods, S. Comer, 1993, The Journal of pharmacology and experimental therapeutics.

Differentiation between mu and kappa receptor-mediated effects in opioid drug discrimination: apparent pA2 analysis.

J. Woods, A. J. Bertalmio, 1987, The Journal of pharmacology and experimental therapeutics.

Mu and Delta opioid receptors activate the same G proteins in human neuroblastoma SH‐SY5Y cells

J. Woods, J. Traynor, A. Alt, 2002, British journal of pharmacology.

Establishing Correlations Between the Pharmacodynamic Characteristics of Opioid Agonists and Their Behavioral Effects

J. Woods, A. J. Bertalmio, 1993 .

Morphine, saline and naltrexone discrimination in morphine-treated pigeons.

J. Woods, C. France, 1987, The Journal of pharmacology and experimental therapeutics.

Opiate agonist-antagonist interactions: application of a three-key drug discrimination procedure.

J. Woods, C. France, 1985, The Journal of pharmacology and experimental therapeutics.

Discriminative stimulus effects of reversible and irreversible opiate agonists: morphine, oxymorphazone and buprenorphine.

J. Woods, C. France, A. E. Jacobson, 1984, The Journal of pharmacology and experimental therapeutics.

Discriminative and aversive properties of beta-carboline-3-carboxylic acid ethyl ester, a benzodiazepine receptor inverse agonist, in rhesus monkeys.

J. Woods, G. Winger, J. Cook, 1986, Life sciences.

Discriminative stimulus effects of naltrexone in narcotic-naive and morphine-treated pigeons.

J. Woods, R. Valentino, S. Herling, 1983, The Journal of pharmacology and experimental therapeutics.

A procedure for rapid evaluation of the discriminative stimulus effects of drugs.

J. Woods, R. Hampton, G. Winger, 1982, Journal of pharmacological methods.

Comparison of discriminative and reinforcing stimulus characteristics of morphine-like opioids and two met-enkephalin analogues

J. Woods, A. Young, S. Herling, 1981, Neuropeptides.

N-Cyclohexylethyl-N-noroxymorphindole: a mu-opioid preferring analogue of naltrindole.

K. Rice, M. Aceto, L. Harris, 2000, Bioorganic & medicinal chemistry letters.

Reinforcing and discriminative stimulus properties of mixed agonist-antagonist opioids.

J. Woods, A. Young, D. Hein, 1984, The Journal of pharmacology and experimental therapeutics.

Acute supersensitivity to the discriminative stimulus effects of naltrexone in pigeons.

J. Woods, C. France, 1988, The Journal of pharmacology and experimental therapeutics.

Narcotic discrimination in pigeons.

J. Woods, R. Valentino, D. Hein, 1980, The Journal of pharmacology and experimental therapeutics.

Discriminative stimulus effects of a centrally administered, delta-opioid peptide (d-Pen2-d-Pen5-enkephalin) in pigeons

H. Mosberg, J. Woods, D. Jewett, 2008, Psychopharmacology.

Discriminative stimulus effects of a centrally administered, delta-opioid peptide (d-Pen2-d-Pen5-enkephalin) in pigeons

H. Mosberg, J. Woods, D. Jewett, 2005, Psychopharmacology.

Discriminative stimulus effects of a centrally administered, delta-opioid peptide (o-Pen2-o-PenS-enkephalin) in pigeons

J. Woods, I. Mosberg, 1996 .

Opioid pharmacology of the antinociceptive effects of loperamide in mice

J. Woods, M. Takasuna, S. S. Negus, 1994, Behavioural pharmacology.

Behavioral and Neurochemical Consequences of Long-Term Intravenous Self-Administration of MDMA and Its Enantiomers by Rhesus Monkeys

G. Ricaurte, J. Woods, M. Kilbourn, 2004, Neuropsychopharmacology.

Cardiovascular Effects of Nicotine, Chlorisondamine, and Mecamylamine in the Pigeon

J. Woods, K. Chadman, 2004, Journal of Pharmacology and Experimental Therapeutics.

Analgesic, anesthetic, and respiratory effects of the competitiveN-methyl-d-aspartate (NMDA) antagonist CGS 19755 in rhesus monkeys

J. Woods, G. Winger, C. France, 1990, Brain Research.

Corticotropin-releasing factor receptor-1: a therapeutic target for cardiac autonomic disturbances

J. Woods, S. Wood, 2007, Expert opinion on therapeutic targets.

Personality: Neurobehavioural Foundation and Pharmacological Protocols

Stephanie A. Carmack, C. McDougle, D. Posey, 2014 .

Antalarmin, a putative CRH-RI antagonist, has transient reinforcing effects in rhesus monkeys

K. Rice, J. Woods, J. Broadbear, 2002, Psychopharmacology.

Clocinnamox inhibits the intravenous self-administration of opioid agonists in rhesus monkeys: comparison with effects on opioid agonist-mediated antinociception

J. Woods, G. Zernig, J. Lewis, 1997, Psychopharmacology.

Buprenorphine and methoclocinnamox: agonist and antagonist effects on respiratory function in rhesus monkeys.

J. Woods, C. Paronis, J. Lewis, 2000, European journal of pharmacology.

Antinociceptive and respiratory effects of nalbuphine in rhesus monkeys.

J. Woods, E. Butelman, C. France, 1994, The Journal of pharmacology and experimental therapeutics.

The phencyclidine (PCP) analog N-[1-(2-benzo(B)thiophenyl) cyclohexyl]piperidine shares cocaine-like but not other characteristic behavioral effects with PCP, ketamine and MK-801.

F. Colpaert, W. Koek, J. Woods, 1989, The Journal of pharmacology and experimental therapeutics.

Antalarmin blockade of corticotropin releasing hormone-induced hypertension in rats

T. Baird, K. Rice, J. Woods, 2000, Brain Research.

Reinforcing and discriminative stimulus effects of the neuroactive steroids pregnanolone and Co 8-7071 in rhesus monkeys

R. B. Carter, P. Wood, J. Woods, 1999, Psychopharmacology.

Morphine Deprivation Increases Self-Administration of the Fast- and Short-Acting μ-Opioid Receptor Agonist Remifentanil in the Rat

Z. Cooper, J. Woods, Yen Nhu-Thi Truong, 2008, Journal of Pharmacology and Experimental Therapeutics.

Quantification of drug choice with the generalized matching law in rhesus monkeys.

Mikhail N. Koffarnus, J. Woods, 2008, Journal of the experimental analysis of behavior.

Relative Reinforcing Effects of Cocaine, Remifentanil, and Their Combination in Rhesus Monkeys

S R Hursh, S. Hursh, J. Woods, 2006, Journal of Pharmacology and Experimental Therapeutics.

Oral self-administration of ethanol, phencyclidine, methadone, pentobarbital and quinine in rhesus monkeys

M. Linnoila, J. Higley, J. Vivian, 1998, Psychopharmacology.

Concurrent performances: reinforcement by different doses of intravenous cocaine in rhesus monkeys.

J. Woods, C. Iglauer, 1974, Journal of the experimental analysis of behavior.

Relative reinforcing strength of three N-methyl-D-aspartate antagonists with different onsets of action.

S R Hursh, K L Casey, S. Hursh, 2002, The Journal of pharmacology and experimental therapeutics.

Buprenorphine-Induced Changes in Mu-Opioid Receptor Availability in Male Heroin-Dependent Volunteers: A Preliminary Study

Robert A Koeppe, Michael R Kilbourn, Mark K Greenwald, 2000, Neuropsychopharmacology.

Transient reinforcing effects of phenylisopropylamine and indolealkylamine hallucinogens in rhesus monkeys

J. Woods, G. Winger, W. Fantegrossi, 2004, Behavioural pharmacology.

The role of endogenous opioids in the luteinizing hormone surge in rats: studies with clocinnamox, a long-lasting opioid receptor antagonist.

E. Young, J. Woods, P. Lieberman, 1998, European journal of pharmacology.

Discriminative-stimulus effects of quipazine and l-5-hydroxytryptophan in relation to serotonin binding sites in the pigeon.

T. Yamamoto, J. Woods, C. Smith, 1991, The Journal of pharmacology and experimental therapeutics.

[3H]dynorphin A binding and kappa selectivity of prodynorphin peptides in rat, guinea-pig and monkey brain.

J. Walker, R. Houghten, J. Woods, 1986, European journal of pharmacology.

Resolution in the receptor binding of putative μ and κ opiates

J. Woods, F. Medzihradsky, S. E. Mitsos, 1984 .

Ventilation in morphine-maintained rhesus monkeys. II: Tolerance to the antinociceptive but not the ventilatory effects of morphine.

J. Woods, C. Paronis, 1997, The Journal of pharmacology and experimental therapeutics.

Enantiomeric and diastereomeric dioxadrols: behavioral, biochemical and chemical determination of the configuration necessary for phencyclidine-like properties.

K. Rice, J. Woods, G. Winger, 1987, The Journal of pharmacology and experimental therapeutics.

Use of in vivo apparent pA2 analysis in assessment of opioid abuse liability.

J. Woods, G. Winger, C. France, 1992, Trends in pharmacological sciences.

Discriminative stimulus effects of dextrorphan in pigeons.

J. Woods, S. Herling, R. E. Solomon, 1983, The Journal of pharmacology and experimental therapeutics.

Maintenance of behavior by ketamine and related compounds in rhesus monkeys with different self-administration histories.

J. Woods, A. Young, 1981, The Journal of pharmacology and experimental therapeutics.

An unusual benzazocine elicits acetylcholine release in the isolated guinea pig ileum

J. Woods, R. Valentino, C. Smith, 1979, Nature.

Kappa-Opioid Receptor Binding Populations in Rhesus Monkey Brain : Relationship to an Assay of Thermal Antinociception 1

H. Mosberg, J. Woods, E. Butelman, 1998 .

Effects of beta-funaltrexamine in normal and morphine-dependent rhesus monkeys: observational studies.

J. Woods, D. Gmerek, 1985, The Journal of pharmacology and experimental therapeutics.

Mirfentanil: pharmacological profile of a novel fentanyl derivative with opioid and nonopioid effects.

K. Rice, J. Woods, G. Winger, 1991, The Journal of pharmacology and experimental therapeutics.

Differential influence of N-dealkylation on the stimulus properties of some opioid agonists.

J. Woods, G. Winger, F. Medzihradsky, 1992, The Journal of pharmacology and experimental therapeutics.

Characterization of butyrylcholinesterase antagonism of cocaine-induced hyperactivity.

J. Woods, L. Koetzner, 2002, Drug metabolism and disposition: the biological fate of chemicals.

Helping older people enjoy life

J. Woods, M. Wagner, 1953 .

Use and abuse of benzodiazepines. Issues relevant to prescribing.

J. Woods, G. Winger, J. Katz, 1988, JAMA.

Antinociceptive and other behavioral effects of the steroid SC17599 are mediated by the mu-opioid receptor.

H. Houshyar, J. Woods, J. Traynor, 2000, European journal of pharmacology.

Progress report from the testing program for stimulant and depressant drugs (1993).

J. Woods, G. Winger, W. Woolverton, 1994, NIDA research monograph.

Progress report from the Testing Program for Stimulant and Depressant Drugs (1990).

J. Woods, G. Winger, W. Woolverton, 1992, NIDA research monograph.

Pharmacological actions of the racemic and the enantiomeric 1,4-dimethyl-10-hydroxy-2,3,4,5,6,7-hexahydro-1,6-methano-1H-4-benz azo nines (C-homobenzomorphans).

M. Aceto, L. Harris, J. Woods, 1985, Japanese journal of pharmacology.

The Fate of Bacterial Cocaine Esterase (CocE): An In Vivo Study of CocE-Mediated Cocaine Hydrolysis, CocE Pharmacokinetics, and CocE Elimination

R. Sunahara, Kathleen R. Noon, J. Woods, 2012, Journal of Pharmacology and Experimental Therapeutics.

Differential Behavioral Tolerance to the δ-Opioid Agonist SNC80 ([(+)-4-[(αR)-α-[(2S,5R)-2,5-Dimethyl-4-(2-propenyl)-1-piperazinyl]-(3-methoxyphenyl)methyl]-N,N-diethylbenzamide) in Sprague-Dawley Rats

E. Jutkiewicz, K. Rice, J. Woods, 2005, Journal of Pharmacology and Experimental Therapeutics.

The δ-Opioid Receptor Agonist (+)BW373U86 Regulates BDNF mRNA Expression in Rats

S. Watson, K. Rice, J. Woods, 2004, Neuropsychopharmacology.

Convulsive Behavior of Nonpeptide δ-Opioid Ligands:Comparison of SNC80 and BW373U86 in Mice

K. Rice, J. Woods, J. Traynor, 1998 .

BW373U86, a delta-opioid receptor agonist, reverses bradykinin-induced thermal allodynia in rhesus monkeys.

J. Woods, S. Negus, E. Butelman, 1995, European journal of pharmacology.

Repeated acquisition of behavioral chains in squirrel monkeys: comparisons of a mu, kappa and delta opioid agonist.

J. Woods, J. M. Moerschbaecher, E. Pakarinen, 1995, The Journal of pharmacology and experimental therapeutics.

Behavioral effects of the systemically active delta opioid agonist BW373U86 in rhesus monkeys.

J. Woods, S. Negus, E. Butelman, 1994, The Journal of pharmacology and experimental therapeutics.

A behavioral economic analysis of cocaine and remifentanil self-administration in rhesus monkeys

J. Woods, G. Winger, Tammy Wade-Galuska, 2007, Psychopharmacology.

Local inhibitory effects of dynorphin A-(1-17) on capsaicin-induced thermal allodynia in rhesus monkeys.

V. Hruby, J. Woods, A. Burritt, 2000, European journal of pharmacology.

Fenfluramine: Amphetamine Congener That Fails to Maintain Drug-Taking Behavior in the Rhesus Monkey

J. Woods, R. Tessel, 1974, Science.

Effects of buprenorphine and other opioid agonists and antagonists on alfentanil- and cocaine-reinforced responding in rhesus monkeys.

J. Woods, G. Winger, P. Skjoldager, 1992, The Journal of pharmacology and experimental therapeutics.

Kappa opioids in rhesus monkeys. I. Diuresis, sedation, analgesia and discriminative stimulus effects.

L. Dykstra, J. Woods, G. Winger, 1987, The Journal of pharmacology and experimental therapeutics.

Benzodiazepines: use, abuse, and consequences.

J. Woods, G. Winger, J. Katz, 1992, Pharmacological reviews.

Most efficient cocaine hydrolase designed by virtual screening of transition states.

Fang Zheng, Chang-Guo Zhan, D. Gao, 2008, Journal of the American Chemical Society.

Reinforcer-dependent enhancement of operant responding in opioid-withdrawn rats

Z. Cooper, J. Woods, Yong‐Gong Shi, 2010, Psychopharmacology.

Behavioral effects of δ-opioid receptor agonists: Potential antidepressants?

E. Jutkiewicz, K. Rice, J. Woods, 2002 .

Reinforcement Properties of Morphine, Cocaine, and SPA as a Function of Unit Dose

J. Woods, C. Schuster, 1968 .

Opioid abuse liability assessment in Rhesus monkeys

J. Woods, G. Winger, K. Schwarz-Stevens, 1993 .

Drug-reinforced responding: rapid determination of dose-response functions.

J. Woods, R. K. Palmer, G. Winger, 1989, Drug and alcohol dependence.

Relative reinforcer magnitude under a nonindependent concurrent schedule of cocaine reinforcement in rhesus monkeys.

J. Woods, C. Iglauer, M. Llewellyn, 1976, Journal of the experimental analysis of behavior.

Behavioral functions of narcotic antagonists: response-drug contingencies.

J. Woods, J. Carney, D. A. Downs, 1975, Federation proceedings.

Morphine: Conditioned Increases in Self-Administration in Rhesus Monkeys

J. Woods, C. Schuster, Stephen R. Goldberg, 1969, Science.

Long-Lasting Effects of a PEGylated Mutant Cocaine Esterase (CocE) on the Reinforcing and Discriminative Stimulus Effects of Cocaine in Rats

R. Sunahara, J. Woods, G. Collins, 2012, Neuropsychopharmacology.

Methoclocinnamox: time course of changes in alfentanil-reinforced responding in rhesus monkeys

J. Woods, G. Winger, R. Briscoe, 2000, Psychopharmacology.

Naltrexone reduces ethanol- and sucrose-reinforced responding in rhesus monkeys

J. Woods, G. Winger, K. Williams, 1998, Psychopharmacology.

Effects of buprenorphine on behavior maintained by heroin and alfentanil in rhesus monkeys

J. Woods, G. Winger, 1996, Behavioural pharmacology.

Antagonistic and rate-suppressing effects of opioid antagonists in the pigeon.

J. Woods, C. France, 1985, The Journal of pharmacology and experimental therapeutics.

Bacterial cocaine esterase: a protein-based therapy for cocaine overdose and addiction.

R. Sunahara, J. Woods, D. Narasimhan, 2012, Future medicinal chemistry.

Subunit Stabilization and Polyethylene Glycolation of Cocaine Esterase Improves In Vivo Residence Time

R. Sunahara, J. Woods, J. Tesmer, 2011, Molecular Pharmacology.

Long-Lasting Effects of Methocinnamox on Opioid Self-Administration in Rhesus Monkeys

S. Husbands, J. Woods, C. France, 2018, The Journal of Pharmacology and Experimental Therapeutics.

Apparent affinity of opioid antagonists in morphine-treated rhesus monkeys discriminating between saline and naltrexone.

K. Rice, J. Woods, B. de Costa, 1990, The Journal of pharmacology and experimental therapeutics.

kappa-Opioid receptor effects of butorphanol in rhesus monkeys.

T. Sumpter, J. Vivian, J. Woods, 1999, The Journal of pharmacology and experimental therapeutics.

Activation of peripheral kappa opioid receptors inhibits capsaicin-induced thermal nociception in rhesus monkeys.

J. Woods, E. Butelman, M. Ko, 1999, The Journal of pharmacology and experimental therapeutics.

k -Opioid Receptor Effects of Butorphanol in Rhesus Monkeys 1

T. Sumpter, J. Vivian, J. Woods, 1999 .

Pharmacological activities of optically pure enantiomers of the κ opioid agonist, U50,488, and its cis diastereomer: evidence for three κ receptor subtypes

K. Rice, J. Woods, R. Rothman, 1989 .

Discriminative and analgesic effects of mu and kappa opioids: in vivo pA2 analysis.

L. Dykstra, J. Woods, A. J. Bertalmio, 1988, Psychopharmacology series.

Behavioral characterization of opioid mixed agonist-antagonists.

J. Woods, G. Winger, 1987, Drug and alcohol dependence.

Antinociceptive, hypothermic, hypotensive, and reinforcing effects of a novel neurotensin receptor agonist, NT69L, in rhesus monkeys

M. Ko, J. Woods, E. Richelson, 2005, Pharmacology Biochemistry and Behavior.

Conditioned effects produced by naltrexone doses that reduce ethanol-reinforced responding in rhesus monkeys.

J. Woods, K. Williams, 1999, Alcoholism, clinical and experimental research.

Receptor reserve and affinity of mu opioid agonists in mouse antinociception: correlation with receptor binding.

J. Woods, J. Broadbear, G. Zernig, 1995, Life sciences.

Effects of GBR 12909 and cocaine on cocaine-maintained behavior in rhesus monkeys.

J. Woods, G. Winger, P. Skjoldager, 1993, Drug and alcohol dependence.

Evaluation of new compounds for opioid activity (1991).

J. Woods, G. Winger, C. Smith, 1992, NIDA research monograph.

Effects of Buprenorphine Maintenance Dose on μ-Opioid Receptor Availability, Plasma Concentrations, and Antagonist Blockade in Heroin-Dependent Volunteers

Robert A Koeppe, Michael R Kilbourn, Mark K Greenwald, 2003, Neuropsychopharmacology.

CHLORPROMAZINE-AND HALOPERIDOL-INDUCED CHANGES IN SOME BEHAVIORAL EFFECTS OF COCAINE AND AMPHETAMINE*

J. Woods, G. Winger, S. Herling, 1978 .

The treatment of chronic insomnia: drug indications, chronic use and abuse liability. Summary of a 2001 New Clinical Drug Evaluation Unit meeting symposium.

Daniel J Buysse, T. Roth, W. Mendelson, 2004, Sleep medicine reviews.

MK-801, a proposed noncompetitive antagonist of excitatory amino acid neurotransmission, produces phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys.

W. Koek, J. Woods, G. Winger, 1988, The Journal of pharmacology and experimental therapeutics.

Training dose: influences in opioid drug discrimination.

J. Woods, C. France, S. Comer, 1991, NIDA research monograph.

β-funaltrexamine antagonizes the discriminative stimulus effects of morphine but not naltrexone in pigeons

J. Woods, C. France, 1987, Psychopharmacology.

Fenfluramine and N-ethyl amphetamine: Comparison of the reinforcing and rate-decreasing actions in the rhesus monkey

J. Woods, R. Tessel, 1975, Psychopharmacologia.

Effects of apomorphine on elicited and operant pecking in pigeons

J. Woods, Joanne S. Abelson, 1980, Psychopharmacology.

Agonist and antagonist properties of serotonergic compounds in pigeons trained to discriminate either quipazine or L-5-hydroxytryptophan.

T. Yamamoto, J. Woods, E. Walker, 1991, The Journal of pharmacology and experimental therapeutics.

Hallucinogen-like actions of 2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) in mice and rats

J. C. Winter, R. Rabin, K. Rice, 2005, Psychopharmacology.

A catalytic antibody against cocaine prevents cocaine's reinforcing and toxic effects in rats.

D. Landry, J. Woods, S. Jamdar, 1998, Proceedings of the National Academy of Sciences of the United States of America.

Rapid and Robust Protection against Cocaine-Induced Lethality in Rats by the Bacterial Cocaine Esterase

I. Wilson, R. Sunahara, E. Jutkiewicz, 2006, Molecular Pharmacology.

Novel Antimuscarinic Antidepressant-like Compounds with Reduced Effects on Cognition

E. Jutkiewicz, A. Coop, J. Woods, 2021, The Journal of Pharmacology and Experimental Therapeutics.

Noncontingent and response-contingent intravenous ethanol attenuates the effect of naltrexone on hypothalamic-pituitary-adrenal activity in rhesus monkeys.

J. Woods, J. Broadbear, K. Williams, 2004, Alcoholism, clinical and experimental research.

Effect of opioid receptor antagonists on hypothalamic–pituitary–adrenal activity in rhesus monkeys

K. Rice, M. Ko, J. Woods, 2003, Psychoneuroendocrinology.

J. Woods, C. France, J. M. Moerschbaecher, 1991, The Journal of pharmacology and experimental therapeutics.

Phencyclidine-like behavioral effects in pigeons induced by systemic administration of the excitatory amino acid antagonist, 2-amino-5-phosphonovalerate.

W. Koek, P. Ornstein, J. Woods, 1986, Life sciences.

Systemic and intracerebroventricular effects of opioid peptides in withdrawn morphine-dependent rhesus monkeys.

J. Woods, J. Katz, C. France, 1983, Life sciences.

Self-administration of methohexital, midazolam and ethanol: effects on the pituitary–adrenal axis in rhesus monkeys

J. Woods, J. Broadbear, G. Winger, 2005, Psychopharmacology.

Effects of (+)-HA-966, CGS-19755, phencyclidine, and dizocilpine on repeated acquisition of response chains in pigeons: systemic manipulation of central glycine sites.

J. Woods, E. Butelman, C. M. Campbell, 1999, The Journal of pharmacology and experimental therapeutics.

Effects of ( 1 )-HA-966 , CGS-19755 , Phencyclidine , and Dizocilpine on Repeated Acquisition of Response Chains in Pigeons : Systemic Manipulation of Central Glycine Sites 1 , 2

J. Woods, E. Butelman, C. M. Campbell, 1999 .

Calculation of agonist efficacy, apparent affinity, and receptor population changes after administration of insurmountable antagonists: comparison of different analytical approaches.

J. Woods, G. Zernig, T. Issaevitch, 1996, Journal of pharmacological and toxicological methods.

Nitric oxide synthase inhibitors produce phencyclidine-like behavioral effects in pigeons

J. Woods, E. Butelman, D. Jewett, 1996, Brain Research.

Phencyclidine-like catalepsy induced by the excitatory amino acid antagonist DL-2-amino-5-phosphonovalerate

W. Koek, J. Woods, E. Kleer, 1986, Behavioural Brain Research.

Phencyclidine (PCP)-like discriminative stimulus effects of metaphit and of 2-amino-5-phosphonovalerate in pigeons: generality across different training doses of PCP

W. Koek, J. Woods, A. E. Jacobson, 2004, Psychopharmacology.

Discriminative stimulus effects of N-substituted analogs of phencyclidine in rhesus monkeys

E. Domino, J. Woods, S. Herling, 1982, Neuropharmacology.

Oral Ethanol-Reinforced Responding in Rhesus Monkeys: Effects of Opioid Antagonists Selective for the Μ-,Κ-, or Δ-Receptor

J. Woods, K. Williams, 1998 .

Restricting benzodiazepine prescribing

J. Woods, G. Winger, J. Katz, 1991, The Lancet.

Irreversible opioid antagonist effects of clocinnamox on opioid analgesia and mu receptor binding in mice.

J. Woods, J. Lewis, T. F. Burke, 1994, The Journal of pharmacology and experimental therapeutics.

Clocinnamox: a novel, systemically-active, irreversible opioid antagonist.

J. Woods, S. Comer, J. Lewis, 1992, The Journal of pharmacology and experimental therapeutics.

Central kappa-opioid receptor-mediated antidepressant-like effects of nor-Binaltorphimine: behavioral and BDNF mRNA expression studies.

S. Watson, Huina Zhang, J. Woods, 2007, European journal of pharmacology.

Comparison of Antinociceptive Effects Induced by Kappa Opioid Agonists in Male and Female Mice.

J. Woods, C. A. Patrick, M. C. Holden Ko, 1999, Analgesia.

PEGylation of bacterial cocaine esterase for protection against protease digestion and immunogenicity.

R. Sunahara, V. Yang, Y. Kwon, 2010, Journal of controlled release : official journal of the Controlled Release Society.

Problems and opportunities in regulation of benzodiazepines.

J. Woods, 1998, Journal of clinical pharmacology.

Endogenous opioids upregulate brain‐derived neurotrophic factor mRNA through δ‐ and µ‐opioid receptors independent of antidepressant‐like effects

S. Watson, Huina Zhang, E. Jutkiewicz, 2006 .

Pharmacological activities of optically pure enantiomers of the kappa opioid agonist, U50,488, and its cis diastereomer: evidence for three kappa receptor subtypes.

K. Rice, J. Woods, R. Rothman, 1989, European journal of pharmacology.

Acquisition of cocaine self-administration with unsignaled delayed reinforcement in rhesus monkeys.

J. Woods, C. Galuska, 2005, Journal of the experimental analysis of behavior.

Relative reinforcing effects of three opioids with different durations of action.

S. Hursh, M. Ko, J. Woods, 2002, The Journal of pharmacology and experimental therapeutics.

Natural and Artificial Enzymes Against Cocaine . I . Monoclonal Antibody 15 A 10 and the Reinforcing Effects of Cocaine in Rats 1 , 2

T. Baird, D. Landry, J. Woods, 2000 .

Local administration of Δ9-tetrahydrocannabinol attenuates capsaicin-induced thermal nociception in rhesus monkeys: a peripheral cannabinoid action

J. Woods, M. Ko, 1999, Psychopharmacology.

Activation of G protein by opioid receptors: role of receptor number and G-protein concentration.

J. Woods, J. Traynor, A. Alt, 2000, European journal of pharmacology.

Constitutive activity of the d -opioid receptor expressed in C6 glioma cells: identiﬁcation of non-peptide d -inverse agonists

H. Akil, C. Neilan, J. Woods, 1999 .

Differential binding properties of oripavines at cloned mu- and delta-opioid receptors.

H. Akil, J. Woods, J. Traynor, 1999, European journal of pharmacology.

Discriminative and reinforcing effects of brotizolam in rhesus monkeys

M. Nader, J. Woods, W. Woolverton, 1991, Psychopharmacology.

Ventilation in morphine-maintained rhesus monkeys. I: Effects of naltrexone and abstinence-associated withdrawal.

J. Woods, C. Paronis, 1997, The Journal of pharmacology and experimental therapeutics.

N-(trifluoromethyl)benzyl substituted N-normetazocines and N-norketobemidones.

M. Aceto, L. Harris, A. Coop, 2003, Bioorganic & medicinal chemistry.

Effects of morphine, naltrexone, and dextrorphan in untreated and morphine-treated pigeons

J. Woods, C. France, 1985, Psychopharmacology.

Design, Preparation, and Characterization of High-Activity Mutants of Human Butyrylcholinesterase Specific for Detoxification of Cocaine

C. Zhan, H. Tai, F. Zheng, 2011, Molecular Pharmacology.

A thermostable bacterial cocaine esterase rapidly eliminates cocaine from brain in nonhuman primates

R. Sunahara, J. Nye, M. Goodman, 2014, Translational Psychiatry.

Aspartame demand in rhesus monkeys: Effects of volume and concentration manipulations

J. Woods, C. Galuska, G. Winger, 2007, Behavioural Processes.

Assessing unit-price related remifentanil choice in rhesus monkeys.

S. Hursh, J. Woods, C. Galuska, 2006, Journal of the experimental analysis of behavior.

Apparent pA2 analysis on the respiratory depressant effects of alfentanil, etonitazene, ethylketocyclazocine (EKC) and Mr2033 in rhesus monkeys.

J. Woods, E. Butelman, C. France, 1993, The Journal of pharmacology and experimental therapeutics.

Respiratory effects of receptor-selective opioids in rhesus monkeys.

J. Woods, C. France, 1990, Progress in clinical and biological research.

THE REINFORCING PROPERTY OF ETHANOL IN THE RHESUS MONKEY: I. INITIATION, MAINTENANCE AND TERMINATION OF INTRAVENOUS ETHANOL‐REINFORCED RESPONDING * †

J. Woods, G. Winger, 1973, Annals of the New York Academy of Sciences.

The influence of esters and carboxylic acids as the N-substituent of opioids. Part 1: Benzomorphans.

M. Aceto, L. Harris, A. Coop, 2008, Bioorganic & medicinal chemistry.

Synthesis and in vitro and in vivo activity of (-)-(1R,5R,9R)- and (+)-(1S,5S,9S)-N-alkenyl-, -N-alkynyl-, and -N-cyanoalkyl-5, 9-dimethyl-2'-hydroxy-6,7-benzomorphan homologues.

M. Aceto, L. Harris, J. Woods, 2000, Journal of medicinal chemistry.

Local administration of mu or kappa opioid agonists attenuates capsaicin-induced thermal hyperalgesia via peripheral opioid receptors in rats

J. Woods, M. Johnson, M. Ko, 2000, Psychopharmacology.

Synthesis, in vitro, and in vivo activity of N-p-substituted-benzyl- (- )- and (+)-N-normetazocines, (-)- and (+)-N-normorphinans, N- norketobemidones, and (-)-N-nor-4,5-epoxymorphinans

M. Aceto, L. Harris, A. Coop, 1998 .

Kappa opioids in rhesus monkeys. II. Analysis of the antagonistic actions of quadazocine and beta-funaltrexamine.

L. Dykstra, J. Woods, G. Winger, 1987, The Journal of pharmacology and experimental therapeutics.

Reinforcing and discriminative-stimulus effects of ephedrine isomers in rhesus monkeys.

J. Woods, G. Winger, W. Woolverton, 2001, Drug and alcohol dependence.

meta Substituted N-ethylamphetamine self injection responding in the rhesus monkey: structure-activity relationships.

J. Woods, R. Tessel, 1978, The Journal of pharmacology and experimental therapeutics.

Structure-activity relationships between meta-substituted N-ethylamphetamines and locomotor activity in mice.

J. Woods, R. Counsell, R. Tessel, 1975, The Journal of pharmacology and experimental therapeutics.

Structural relationship between meta substituted N ethyl amphetamines and self administration in rhesus monkeys

J. Woods, R. Tessel, 1974 .

Cell permeable cocaine esterases constructed by chemical conjugation and genetic recombination.

R. Sunahara, V. Yang, J. Woods, 2012, Molecular pharmaceutics.

Zomepirac: preclinical narcotic abuse liability evaluation.

M. Aceto, L. Harris, J. Woods, 1983, Arzneimittel-Forschung.

Yawning and hypothermia in rats: effects of dopamine D3 and D2 agonists and antagonists

Shaomeng Wang, Jianyong Chen, A. Newman, 2007, Psychopharmacology.

Proerectile Effects of Dopamine D2-Like Agonists Are Mediated by the D3 Receptor in Rats and Mice

D. Grandy, Shaomeng Wang, R. Sunahara, 2009, Journal of Pharmacology and Experimental Therapeutics.

Evaluation of new compounds for opioid activity.

J. Woods, G. Winger, C. Smith, 1988, NIDA research monograph.

Structural analysis of thermostabilizing mutations of cocaine esterase.

J. Macdonald, R. Sunahara, D. Gao, 2010, Protein engineering, design & selection : PEDS.

Oral ethanol self-administration in rhesus monkeys: behavioral and neurochemical correlates.

M. Linnoila, J. Higley, J. Vivian, 1999, Alcoholism, clinical and experimental research.

Chlorpromazine effects on cocaine-reinforced responding in rhesus monkeys: reciprocal modification of rate-altering effects of the drugs.

J. Woods, S. Herling, 1980, The Journal of pharmacology and experimental therapeutics.

Behavioral effects of flunitrazepam: reinforcing and discriminative stimulus effects in rhesus monkeys and prevention of withdrawal signs in pentobarbital-dependent rats.

L. Harris, J. Woods, G. Winger, 2001, Drug and Alcohol Dependence.

Evaluation of the reinforcing and discriminative stimulus effects of gamma-hydroxybutyrate in rhesus monkeys.

J. Woods, G. Winger, C. France, 1999, Drug and alcohol dependence.

Dipsogenic effects of excitatory amino acid agonists in pigeons.

J. Woods, S. Baron, 1993, The Journal of pharmacology and experimental therapeutics.

Diltiazem enhances the analgesic but not the respiratory depressant effects of morphine in rhesus monkeys.

M. Ko, J. Woods, S. Kishioka, 2000, European journal of pharmacology.

Cocaine, d-amphetamine, and pentobarbital effects on responding maintained by food or cocaine in rhesus monkeys

J. Woods, D. A. Downs, S. Herling, 1979, Psychopharmacology.

A Procedure for Rapid Evaluation of the Stimulus Effects of Drugs

J. Woods, A. J. Bertalmio, Seymore Herlinc, 1982 .

Opiates as Reinforcing Stimuli

J. Woods, C. Schuster, 1971 .

Individual differences in discount rate are associated with demand for self‐administered cocaine, but not sucrose

Mikhail N. Koffarnus, J. Woods, 2013, Addiction biology.

Benzodiazepine dependence studies in animals: An overview

J. Woods, 1982 .

Naloxone as a negative reinforcer in rhesus monkeys: effects of dose, schedule, and narcotic regimen.

J. Woods, D. A. Downs, 1975, Pharmacological reviews.

The relationship between the acute behavioral effects of narcotic antagonists and the narcotic-dependent state [proceedings].

J. Woods, R. Valentino, S. Herling, 1981, Psychopharmacology bulletin.

Changes in Operant Behavior During Deprivation- and Antagonist-Induced Withdrawal States

J. Woods, J. Villarreal, D. A. Downs, 1973 .

Studies of μ-, κ-, and δ-Opioid Receptor Density and G Protein Activation in the Cortex and Thalamus of Monkeys

M. Ko, J. Woods, J. Traynor, 2003, Journal of Pharmacology and Experimental Therapeutics.

The effects of chronic morphine on behavior reinforced by several opioids or by cocaine in rhesus monkeys.

J. Woods, G. Winger, J H Woods, 2001, Drug and alcohol dependence.

Ethanol as a Reinforcer: Comparison with Other Drugs

J. Woods, A. Young, G. Winger, 1983 .

The Conditioned Reinforcing Effects of Stimuli Associated with Morphine Reinforcement

J. Woods, C. Schuster, 1968 .

Agonist and antagonist effects of dynorphin A-(1-13) in a thermal antinociception assay in rhesus monkeys.

J. Woods, E. Butelman, C. France, 1995, Journal of Pharmacology and Experimental Therapeutics.

History of drug exposure as a determinant of drug self-administration.

J. Woods, A. Young, S. Herling, 1981, NIDA research monograph.

Barbiturate-reinforced responding in rhesus monkeys: comparisons of drugs with different durations of action.

M. Stitzer, J. Woods, G. Winger, 1975, The Journal of pharmacology and experimental therapeutics.

NARCOTIC DISCRIMINATION IN PIGEONS: ANTAGONISM

J. Woods, R. Valentino, S. Herling, 2002 .

Narcotic discrimination in pigeons: antagonism by naltrexone.

J. Woods, R. Valentino, S. Herling, 1984, European journal of pharmacology.

Classification of narcotics on the basis of their reinforcing, discriminative, and antagonist effects in rhesus monkeys.

J. Woods, A. Young, S. Herling, 1982, Federation proceedings.

Fixed-ratio escape and avoidance-escape from naloxone in morphine-dependent monkeys: effects of naloxone dose and morphine pretreatment.

J. Woods, D. A. Downs, 1975, Journal of the experimental analysis of behavior.

Discriminative stimulus effects of BW373U86: a nonpeptide ligand with selectivity for delta opioid receptors.

H. Mosberg, J. Woods, S. Comer, 1993, The Journal of pharmacology and experimental therapeutics.

Discriminative stimulus effects of opioid agonists in morphine-dependent pigeons.

J. Woods, C. France, 1990, The Journal of pharmacology and experimental therapeutics.

Stereospecificity of narcotic- and phencyclidine-like behavioral properties of some 6,7-benzomorphans in the rhesus monkey

J. Woods, S. Herling, R. E. Solomon, 1981 .

Pharmacological evaluation of the adequacy of marble burying as an animal model of compulsion and/or anxiety

J. Woods, Corina Jimenez‐Gomez, Andrew Osentoski, 2011, Behavioural pharmacology.

Structural determinants of opioid activity in derivatives of 14-aminomorphinones: effect of substitution in the aromatic ring of cinnamoylaminomorphinones and codeinones.

S. Husbands, J. Lewis, J. Woods, 2006, Journal of medicinal chemistry.

Cinnamoyl Derivatives of 7α‐Amino‐ and 7α‐(Aminomethyl)‐ N‐(cyclopropylmethyl)‐6,14‐endo‐ethanotetrahydronororipavines are High‐Potency Opioid Antagonists

S. Husbands, J. Lewis, J. Woods, 2000 .

Cinnamoyladmidomethyloripavines: preliminary in vivo evaluation of potential new affinity ligands for opioid receptors

J. Lewis, J. Woods, J. Broadbear, 1995 .

Schedule-Induced Polydipsia in the Rhesus Monkey

J. Woods, C. Schuster, 1966, Psychological reports.

Experimental abuse liability assessment of benzodiazepines.

J. Woods, 1983, Journal of psychoactive drugs.

Behavior maintained by intravenous injection of codeine, cocaine, and etorphine in the rhesus macaque and the pigtail macaque

J. Woods, A. Young, 1980, Psychopharmacology.

A choice procedure to assess the aversive effects of drugs in rodents.

Christopher A. Podlesnik, J. Woods, Corina Jimenez‐Gomez, 2010, Journal of the experimental analysis of behavior.

Introduction

J. Woods, 1989, Pharmacology Biochemistry and Behavior.

Very long-acting narcotic antagonists: the 14 beta-p-substituted cinnamoylaminomorphinones and their partial mu agonist codeinone relatives.

M. Aceto, L. Harris, J. Woods, 1989, Arzneimittel-Forschung.

Food Restriction Alters N′-Propyl-4,5,6,7-tetrahydrobenzothiazole-2,6-diamine dihydrochloride (Pramipexole)-Induced Yawning, Hypothermia, and Locomotor Activity in Rats: Evidence for Sensitization of Dopamine D2 Receptor-Mediated Effects

D. Calinski, A. Newman, J. Woods, 2008, Journal of Pharmacology and Experimental Therapeutics.

14 beta-O-cinnamoylnaltrexone and related dihydrocodeinones are mu opioid receptor partial agonists with predominant antagonist activity.

S. Husbands, J. Woods, J. Traynor, 2009, Journal of medicinal chemistry.

Food restriction and sex differences on concurrent, oral ethanol and water reinforcers in juvenile rhesus monkeys.

J. Woods, K. Williams, E. Pakarinen, 1999, Alcohol.

3-Deoxyclocinnamox: the first high-affinity, nonpeptide mu-opioid antagonist lacking a phenolic hydroxyl group.

C. Neilan, S. Husbands, J. Woods, 2000, Journal of medicinal chemistry.

3-Alkyl ethers of clocinnamox : Delayed long-term μ-antagonists with variable μ efficacy

M. Aceto, L. Harris, S. Husbands, 1998 .

Methoclocinnamox: a mu partial agonist with pharmacotherapeutic potential for heroin abuse.

J. Woods, E. Butelman, J. Broadbear, 1995, NIDA research monograph.

In vivo determination of μ opioid receptor reserve and turnover in rhesus monkeys after irreversible blockade with clocinnamox

J. Woods, E. Butelman, G. Zernig, 1994, Regulatory Peptides.

Behavioral sensitization to cocaine in rats: evidence for temporal differences in dopamine D3 and D2 receptor sensitivity

Shaomeng Wang, Jianyong Chen, J. Woods, 2011, Psychopharmacology.

Thermostable Variants of Cocaine Esterase for Long-Time Protection against Cocaine Toxicity

Chang-Guo Zhan, Joanne Macdonald, J. Macdonald, 2009, Molecular Pharmacology.

Cocaine Esterase: Interactions with Cocaine and Immune Responses in Mice

R. Sunahara, Z. Cooper, J. Woods, 2007, Journal of Pharmacology and Experimental Therapeutics.

Influence of conditioned reinforcement on the response-maintaining effects of quinpirole in rats

J. Woods, G. Collins, 2009, Behavioural pharmacology.

A bacterial cocaine esterase protects against cocaine-induced epileptogenic activity and lethality.

R. Sunahara, E. Jutkiewicz, Z. Cooper, 2009, Annals of emergency medicine.

Tetrabenazine fails to antagonize a behavioral effect of cocaine in rhesus monkeys

T. Sumpter, J. Woods, L. Koetzner, 2002, Pharmacology Biochemistry and Behavior.

Self-administration of agonists selective for dopamine D2, D3, and D4 receptors by rhesus monkeys

Mikhail N. Koffarnus, Jianyong Chen, K. Rice, 2012, Behavioural pharmacology.

Effects of the delta-opioid receptor agonist SNC80 on learning relative to its antidepressant-like effects in rats

E. Jutkiewicz, J. Woods, P. Winsauer, 2003, Behavioural pharmacology.

Oral ethanol-reinforced responding in rhesus monkeys: effects of opioid antagonists selective for the mu-, kappa-, or delta-receptor.

J. Woods, K. Williams, 1998, Alcoholism, clinical and experimental research.

BU48: a novel buprenorphine analog that exhibits delta-opioid-mediated convulsions but not delta-opioid-mediated antinociception in mice.

A. Coop, S. Husbands, J. Woods, 2000, The Journal of pharmacology and experimental therapeutics.

Behavioral effects of fentanyl derivatives in rhesus monkeys

J. Woods, G. Winger, C. France, 1994, Regulatory Peptides.

Pharmacological profile of a potent, efficacious fentanyl derivative in rhesus monkeys

K. Rice, J. Woods, G. Winger, 2005, Psychopharmacology.

Reinforcing and discriminative stimulus effects of 1-benzylpiperazine and trifluoromethylphenylpiperazine in rhesus monkeys.

A. Coop, J. Woods, G. Winger, 2005, Drug and alcohol dependence.

Effects of pramipexole on the reinforcing effectiveness of stimuli that were previously paired with cocaine reinforcement in rats

Shaomeng Wang, Jianyong Chen, A. Newman, 2011, Psychopharmacology.

Response repetition in pigeons: pharmacological and behavioral specificity

W. Koek, J. Woods, 2004, Psychopharmacology.

Comparison of Peptidic and Nonpeptidic (cid:1) -Opioid Agonists on Guanosine 5 (cid:1) - O -(3-[ 35 S]thio)triphosphate ([ 35 S]GTP (cid:2) S) Binding in Brain Slices from Sprague-Dawley Rats

E. Jutkiewicz, K. Rice, J. Woods, 2005 .

Differential behavioral tolerance to the delta-opioid agonist SNC80 ([(+)-4-[(alphaR)-alpha-[(2S,5R)-2,5-dimethyl-4-(2-propenyl)-1-piperazinyl]-(3-methoxyphenyl)methyl]-N,N-diethylbenzamide) in Sprague-Dawley rats.

E. Jutkiewicz, K. Rice, J. Woods, 2005, The Journal of pharmacology and experimental therapeutics.

Delta-opioid agonists: differential efficacy and potency of SNC80, its 3-OH (SNC86) and 3-desoxy (SNC162) derivatives in Sprague-Dawley rats.

E. Jutkiewicz, K. Rice, J. Woods, 2004, The Journal of pharmacology and experimental therapeutics.

Analgesic effects of phencyclidine-like drugs in rhesus monkeys.

J. Woods, C. France, A. Snyder, 1989, Journal of Pharmacology and Experimental Therapeutics.

The discriminative stimulus effects of dopamine D2- and D3-preferring agonists in rats

Mikhail N. Koffarnus, A. Newman, S. Husbands, 2009, Psychopharmacology.

Identification and Characterization of ML321: a Novel and Highly Selective D2 Dopamine Receptor Antagonist with Efficacy in Animal Models that Predict Atypical Antipsychotic Activity

R. Rodriguiz, W. Wetsel, R. Mach, 2022, bioRxiv.

Partial generalization in pigeons trained to discriminate morphine from saline: Applications of receptor theory

W. Koek, J. Woods, 1989 .

Comparison of discriminative and reinforcing effects of ketamine and related compounds in the rhesus monkey.

J. Woods, A. Young, G. Winger, 1981, NIDA research monograph.

Effects of pentobarbital on fixed-ratio discrimination*

J. Woods, J. Rosenberg, 1975 .

Interactions between N-methyl-D-aspartate and CGS 19755 administered intramuscularly and intracerebroventricularly in pigeons.

J. Woods, Y. Lu, C. France, 1990, The Journal of pharmacology and experimental therapeutics.

Phencyclidine-induced catalepsy in pigeons: specificity and stereoselectivity.

W. Koek, T. Burke, K. Rice, 1984, European journal of pharmacology.

Observing responses maintained by stimuli associated with cocaine or remifentanil reinforcement in rhesus monkeys

J. Woods, G. Winger, 2002, Psychopharmacology.

A simple and rapid method for assessing similarities among directly observable behavioral effects of drugs: PCP-like effects of 2-amino-5-phosphonovalerate in rats

W. Koek, P. Ornstein, J. Woods, 2004, Psychopharmacology.

Structure-activity relationships between meta-substituted N-ethylamphetamines and isolated guinea-pig atrial rate.

J. Woods, R. Counsell, R. Tessel, 1975, Journal of Pharmacology and Experimental Therapeutics.

The Ability of Bacterial Cocaine Esterase to Hydrolyze Cocaine Metabolites and Their Simultaneous Quantification Using High-Performance Liquid Chromatography-Tandem Mass Spectrometry

R. Sunahara, Kathleen R. Noon, J. Woods, 2011, Molecular Pharmacology.

Discriminative stimulus characteristics of BMY 14802 in the pigeon.

W. Essman, J. Woods, S. A. Vanecek, 1998, The Journal of pharmacology and experimental therapeutics.

Repeated Administration of a Mutant Cocaine Esterase: Effects on Plasma Cocaine Levels, Cocaine-Induced Cardiovascular Activity, and Immune Responses in Rhesus Monkeys

R. Sunahara, Kathleen R. Noon, J. Woods, 2012, Journal of Pharmacology and Experimental Therapeutics.

Evaluation of the hydrolytic activity of a long-acting mutant bacterial cocaine in the presence of commonly co-administered drugs.

R. Sunahara, Kathleen R. Noon, J. Woods, 2011, Drug and alcohol dependence.

The delta-opioid receptor agonist (+)BW373U86 regulates BDNF mRNA expression in rats.

S. Watson, K. Rice, J. Woods, 2004, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

Behavioral effects of delta-opioid receptor agonists: potential antidepressants?

E. Jutkiewicz, K. Rice, J. Woods, 2002, Japanese journal of pharmacology.

Rebuttal of comments by Griffiths, Lader and Greenblatt to Review by Woods and Winger

J. Woods, G. Winger, 1995, Psychopharmacology.

Compounds of novel structure having kappa-agonist behavioral effects in rhesus monkeys.

J. Woods, G. Winger, J. Katz, 1982, Life sciences.

Characterization of equine butyrylcholinesterase disposition in the mouse.

J. Woods, L. Koetzner, 2002, Drug metabolism and disposition: the biological fate of chemicals.

A Handbook on Drug and Alcohol Abuse: The Biomedical Aspects

J. Woods, G. Winger, F. Hofmann, 1975 .

Patterns of nicotinic receptor antagonism II: cardiovascular effects in rats.

E. Jutkiewicz, F. Carroll, J. Woods, 2013, Drug and alcohol dependence.

Effects of cocaine esterase following its repeated administration with cocaine in mice.

R. Sunahara, J. Woods, N. Lukacs, 2009, Drug and alcohol dependence.

Design, synthesis, and evaluation of potent and selective ligands for the dopamine 3 (D3) receptor with a novel in vivo behavioral profile.

Jian Zhang, James Woods, Chao-Yie Yang, 2008, Journal of medicinal chemistry.

Effects of morphine and ketorolac on thermal allodynia induced by prostaglandin E2 and bradykinin in rhesus monkeys.

J. Woods, S. Negus, E. Butelman, 1995, The Journal of pharmacology and experimental therapeutics.

Naloxone benzylhydrazone is a μ‐selective opioid antagonist without κ agonist effects in rhesus monkeys

J. Woods, C. France, 1992, Behavioural pharmacology.

Fixed-ratio schedules of cocaine self-administration in rhesus monkeys: joint control of responding by past and upcoming doses

J. Woods, G. Winger, Chad M. Galuska, 2007, Behavioural pharmacology.

A catalytic antibody against cocaine attenuates cocaine's cardiovascular effects in mice: a dose and time course analysis.

T. Baird, D. Landry, J. Woods, 2001, International immunopharmacology.

6N-Cinnamoyl-β-naltrexamine and its p-nitro derivative. High efficacy κ-opioid agonists with weak antagonist actions

J. Lewis, J. Woods, J. Broadbear, 1996 .

Correlations among certain behavioral, physiological, and biochemical effects of narcotic agonists.

J. Woods, A. Young, J. Katz, 1981, NIDA research monograph.

The ascending limb of the cocaine dose-response curve for reinforcing effect in rhesus monkeys

J. Woods, G. S. Flory, 2003, Psychopharmacology.

14-β-Cinnamoylamidomorphinones and codeinones. Analogues of the selective irreversible antagonist clocinnamox

J. Lewis, J. Woods, J. Broadbear, 1995 .

MOLECULAR MODELLING OF FUMARAMIDO AND CINNAMOYLAMIDO DERIVATIVES IN EPOXY-MORPHINANS. CORRELATION WITH PHARMACOLOGICAL PROFILES.

S. Husbands, J. Woods, H. Moynihan, 1995 .

Characterisation of [3H]clocinnamox binding in mouse brain membranes

J. Woods, G. Zernig, Jw Lewis, 1995 .

Design, Preparation, and Characterization of High-Activity Mutants of Human Butyrylcholinesterase Specific for Detoxification of Cocaine

C. Zhan, H. Tai, F. Zheng, 2011, Molecular Pharmacology.

Most efficient cocaine hydrolase designed by virtual screening of transition states.

D. Gao, C. Zhan, H. Tai, 2008, Journal of the American Chemical Society.

Variable interval responding maintained by intravenous codeine and ethanol injections in the rhesus monkey

J. Woods, J. Carney, M. Llewellyn, 1976, Pharmacology Biochemistry and Behavior.

OF THE EXPERIMENTAL ANALYSIS OF BEHAVIOR ANALYSIS OF FIXED-RATIO BEHA VIOR MAINTAINED BY DRUG REINFORCERS

J. Woods, G. Winger, P. Skjoldager, 2005 .

Excitatory amino acid antagonists induce a phencyclidine-like catalepsy in pigeons: Structure-activity studies

W. Koek, J. Woods, M. Mattson, 1987, Neuropharmacology.

Discriminative stimulus effects of monohydroxylated phencyclidine metabolites in Rhesus monkeys.

J. Woods, S. Herling, R. E. Solomon, 1982, European journal of pharmacology.

Discriminative stimulus, antagonist, and rate-decreasing effects of cyclorphan: multiple modes of action.

J. Woods, R. Valentino, D. Hein, 1982, Life sciences.

J. Woods, G. Winger, D. Hein, 2004, Psychopharmacology.

Pharmacokinetic evidence for the long-lasting effect of nor-binaltorphimine, a potent kappa opioid receptor antagonist, in mice

J. Woods, M. Ko, N. Kiguchi, 2013, Neuroscience Letters.

Effects of pramipexole on the acquisition of responding with opioid-conditioned reinforcement in the rat

Jianyong Chen, J. Woods, Jeremiah W. Bertz, 2014, Psychopharmacology.

Behavioral perspectives on the neuroscience of drug addiction.

J. Woods, G. Winger, Chad M. Galuska, 2005, Journal of the experimental analysis of behavior.